<?xml version="1.0" encoding="UTF-8"?>
<ref id="cas14841-bib-0003">
 <label>3</label>
 <mixed-citation publication-type="journal" id="cas14841-cit-0003">
  <string-name>
   <surname>Parikh</surname>
   <given-names>AR</given-names>
  </string-name>, 
  <string-name>
   <surname>Lee</surname>
   <given-names>FC</given-names>
  </string-name>, 
  <string-name>
   <surname>Yau</surname>
   <given-names>L</given-names>
  </string-name>, et al. 
  <article-title>MAVERICC, a randomized, biomarker‐stratified, Phase II Study of mFOLFOX6‐Bevacizumab versus FOLFIRI‐Bevacizumab as First‐line Chemotherapy in Metastatic Colorectal Cancer</article-title>. 
  <source xml:lang="en">Clin Cancer Res</source>. 
  <year>2019</year>;
  <volume>25</volume>(
  <issue>10</issue>):
  <fpage>2988</fpage>‐
  <lpage>2995</lpage>.
  <pub-id pub-id-type="pmid">30224341</pub-id>
 </mixed-citation>
</ref>
